Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
about
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
description
clinical trial
@en
klinisch onderzoek
@nl
name
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
@en
Zenapax
@nl
type
label
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
@en
Zenapax
@nl
prefLabel
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
@en
Zenapax
@nl
P1476
Zenapax (Daclizumab) Admin to ...... in the Central Nervous System
@en
P3098
NCT00071838
P580
2003-10-30T00:00:00Z
P582
2007-10-04T00:00:00Z